The Hill Group in the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center are conducting multiple epidemiologic and translational studies of strategies to improve the diagnosis, treatment, and prevention of infections after CAR-T cell therapy, hematopoietic cell transplantation, and other immunosuppressive treatments.